Pharmaceutical News

RSS

Clinical study finds two topical skin creams as effective noninvasive treatments for low-risk superficial BCC

Basal cell carcinoma is one of the most common cancers and its incidence is increasing worldwide, putting a significant burden on health services. Topical treatments are available for superficial basal cell carcinoma (BCC) but there has a lack of long-term follow-up data to guide treatment decisions.

3 Jun 2016

BetterYou’s DLuxPregnancy daily vitamin D oral spray offers more effective solution than tablets for expectant mums

A simple daily oral vitamin D spray by health pioneers BetterYou, can offer a more effective solution than tablets for expectant mums urged to boost vitamin D and folic acid levels.

From BetterYou Ltd 3 Jun 2016

Fasnall drug appears to inhibit tumor growth by promoting cancer cell death

A promising new compound appears to impede a process that fuels breast cancer in mice, a discovery that could have implications in the treatment of a host of cancers.

3 Jun 2016

Immunotherapy with experimental monoclonal antibody could reduce neuroblastoma tumors

Neuroblastoma tumors shrank, some dramatically, in 80 percent of newly diagnosed, young, high-risk patients enrolled in a Phase II clinical trial that included an experimental monoclonal antibody. The immunotherapy agent was produced on the St. Jude Children's Research Hospital campus where the study is still underway.

3 Jun 2016

Analysing blood metabolites may help monitor effects of novel drugs

Testing for metabolic changes in the blood could indicate whether a cancer drug is working as designed, a new study reports.

3 Jun 2016

New mouse model allows researchers to evaluate CD40-antibody drugs effectively

Cancer immunotherapies--drugs that work by making a patient's immune system better at spotting and destroying tumor cells--are increasingly generating headlines. A number of these drugs are now being used for the treatment of melanoma, lung, and kidney cancers, and are showing promise in clinical trials with other diseases as well.

3 Jun 2016

New research explores women’s perspective about medication use during pregnancy

Pregnant women overestimate the risks of taking over the counter and prescribed medication - according to new research from the University of East Anglia.

3 Jun 2016

Maternal vaccination against influenza can reduce flu risk in newborns

Each year, influenza causes between 250,000 and half a million deaths around the world. Pregnant women and young infants have a higher risk of complications related to influenza; these complications can easily lead to death.

3 Jun 2016

New dietary supplement can prevent, reverse massive brain cell loss

A dietary supplement containing a blend of thirty vitamins and minerals--all natural ingredients widely available in health food stores--has shown remarkable anti-aging properties that can prevent and even reverse massive brain cell loss, according to new research from McMaster University.

3 Jun 2016

Retroviral replicating vector can extend lives of brain cancer patients

Doctors at UCLA, Cleveland Clinic, University of California San Diego School of Medicine and additional institutions have achieved a milestone in the development of a treatment for people with recurrent glioblastoma, the most common and aggressive form of brain cancer, by successfully demonstrating a modified virus that can extend the lives of patients with the disease.

2 Jun 2016

Nivolumab and ipilimumab combination could lead to effective treatment options for SCLC patients

Small cell lung cancer (SCLC) represents approximately 14 percent of all types of lung cancer. Many patients with SCLC respond to initial chemotherapy; however, they eventually relapse and develop progressive disease that has no effective treatment options.

2 Jun 2016

New technique could help reduce chances of drug failure during later stages of clinical trials

An approach that could reduce the chances of drugs failing during the later stages of clinical trials has been demonstrated by a collaboration between the University of Cambridge and pharmaceutical company GlaxoSmithKline.

2 Jun 2016

FDA approves blood-based cobas EGFR Mutation Test v2 for NSCLC patients

The U.S. Food and Drug Administration today approved the cobas EGFR Mutation Test v2, a blood-based companion diagnostic for the cancer drug Tarceva (erlotinib). This is the first FDA-approved, blood-based genetic test that can detect epidermal growth factor receptor (EGFR) gene mutations in non-small cell lung cancer patients.

2 Jun 2016

New drugs show promise as first antidote for radiation exposure

University of Virginia School of Medicine researchers have identified promising drugs that could lead to the first antidote for radiation exposure that might result from a dirty bomb terror attack or a nuclear accident such as Chernobyl.

2 Jun 2016

Duke scientists discover new small-molecule drugs to treat chronic pain

A research team at Duke University has discovered a potential new class of small-molecule drugs that simultaneously block two sought-after targets in the treatment of pain.

1 Jun 2016

Denosumab drug that inhibits RANKL gene can prevent genetic breast cancer

An international team led by researchers at the Austrian Institute of Molecular Biotechnology in Vienna and the University of Maryland School of Medicine in Baltimore discovered that genetically determined breast cancer can be largely prevented by blocking a bone gene. An already approved drug could be quickly available and would then be the first breast cancer prevention drug.

1 Jun 2016

Understanding how opiates affect brain pathways to drive addiction cycle

New research by Steven Laviolette's research team at Western University is contributing to a better understanding of the ways opiate-class drugs modify brain circuits to drive the addiction cycle.

1 Jun 2016

Ocaliva drug gets FDA approval for primary biliary cholangitis treatment

On Friday, May 27, the U.S. Food and Drug Administration granted accelerated approval for Ocaliva (obeticholic acid) for the treatment of primary biliary cholangitis (PBC) in combination with ursodeoxycholic acid (UDCA) in adults with an inadequate response to UDCA, or as a single therapy in adults unable to tolerate UDCA.

1 Jun 2016

TSRI scientists develop first drug candidate that neutralizes disease-causing RNA repeats

In an important new study with implications for the treatment of dozens of incurable diseases, scientists from the Florida campus of The Scripps Research Institute have for the first time created a drug candidate that attacks and neutralizes the RNA structure that causes an incurable progressive, inherited disease involving a gradual loss of control over body movement.

1 Jun 2016

BetterYou wins top prize at Veggie Awards for TotalNutrition Superfood powder

A unique blend of organically harvested superfoods created by health pioneers BetterYou, has scooped the top prize in the Best Supplement category at the Veggie Awards, a true mark of quality in the meat-free industry.

From BetterYou Ltd 1 Jun 2016

Pharmaceutical News

Clinical study finds two topical skin creams as effective noninvasive treatments for low-risk superficial BCC

BetterYou’s DLuxPregnancy daily vitamin D oral spray offers more effective solution than tablets for expectant mums

Fasnall drug appears to inhibit tumor growth by promoting cancer cell death

Immunotherapy with experimental monoclonal antibody could reduce neuroblastoma tumors

Analysing blood metabolites may help monitor effects of novel drugs

New mouse model allows researchers to evaluate CD40-antibody drugs effectively

New research explores women’s perspective about medication use during pregnancy

Maternal vaccination against influenza can reduce flu risk in newborns

New dietary supplement can prevent, reverse massive brain cell loss

Retroviral replicating vector can extend lives of brain cancer patients

Nivolumab and ipilimumab combination could lead to effective treatment options for SCLC patients

New technique could help reduce chances of drug failure during later stages of clinical trials

FDA approves blood-based cobas EGFR Mutation Test v2 for NSCLC patients

New drugs show promise as first antidote for radiation exposure

Duke scientists discover new small-molecule drugs to treat chronic pain

Denosumab drug that inhibits RANKL gene can prevent genetic breast cancer

Understanding how opiates affect brain pathways to drive addiction cycle

Ocaliva drug gets FDA approval for primary biliary cholangitis treatment

TSRI scientists develop first drug candidate that neutralizes disease-causing RNA repeats

BetterYou wins top prize at Veggie Awards for TotalNutrition Superfood powder

PhD researcher at LifeArc

Unveiling Hidden Potential: Organoids for Disease Modeling in Neuroscience Research

How GLP‑1 Agonists Are Shaping the Future of Obesity Treatment With Dr Bryony Henderson

Latest News